Medscape Medical NewsAll articles

DTX Studio Clinic (4.0)

Nobel Biocare AB • Radiology • 12/08/2023

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

DTX Studio Clinic (4.0) is a software product classified as a Medical Image Analyzer, intended for the analysis of medical images within clinical environments. Its development, manufacturing, and marketing are governed by medical device regulations, including comprehensive Quality System requirements that mandate robust design controls and adherence to good manufacturing practices.

Summary

DTX Studio Clinic (4.0), from Nobel Biocare AB, is a software device identified under the regulation name 'Medical Image Analyzer' (21 CFR 892.2070) and product code MYN. This indicates its primary purpose is the analysis of medical images to assist healthcare professionals. The device is subject to general controls provisions applicable to medical devices, which include requirements for annual registration, device listing, adherence to good manufacturing practices, proper labeling, and prohibitions against misbranding and adulteration. As a Class II device, DTX Studio Clinic (4.0) is also governed by additional special controls, notably the Quality System (QS) regulation found in 21 CFR Part 820. This regulation imposes stringent requirements, including the implementation of design controls (21 CFR 820.30) to ensure appropriate development, procedures for managing nonconforming products (21 CFR 820.90), and the establishment of corrective and preventive actions (21 CFR 820.100). Manufacturers are further obligated to review, approve, and meticulously document any changes to the device's design and production processes in the device master record, ensuring ongoing compliance and safety.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

DTX Studio Clinic (4.0)Medical Image AnalyzerSoftwareNobel Biocare ABClass II Device21 CFR 892.2070MYN (Product Code)Quality System RegulationDesign ControlsGood Manufacturing Practice

Device Metadata

Submission Number
K231898
Company
Nobel Biocare AB
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Intervention
AI Function
Analysis
AI Subclass
detection

Relevant Clinical Questions

  • Q1. What specific types of medical images is DTX Studio Clinic (4.0) designed to analyze, and for what clinical specialties (e.g., dental, general radiology)?; What are the core functionalities and analytical capabilities of DTX Studio Clinic (4.0) that classify it as a 'Medical Image Analyzer'?; How does version 4.0 of DTX Studio Clinic enhance or differ from previous versions or similar image analysis software in terms of features or performance benchmarks?; What level of training or specific expertise is recommended or required for clinicians to effectively and safely utilize DTX Studio Clinic (4.0) for its intended image analysis purposes?; What are the known limitations, contraindications, or specific patient populations for which the use of DTX Studio Clinic (4.0) might be less suitable or require particular caution?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment⚠ Not in summary - likely in full submission per §524B
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(labeling)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, OBOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
DTX Studio Clinic (4.0) - Nobel Biocare AB | ESL FDA AI Device Intelligence